BRAF V600E/TERT promoter mutations and NIS/TSHR expression in differentiated thyroid carcinomaand th

来源 :肿瘤学与转化医学:英文版 | 被引量 : 0次 | 上传用户:wangzhaolinghappy
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective Telomerase reverse transcriptase (TERT) promoter mutations have recently been describedin thyroid carcinoma. The purpose of this study was to investigate the clinical significance of (v-raf murinesarcoma viral oncogene homolog B1) BRAF V600E and
其他文献
Colorectal cancer(CRC) is a biologically heterogeneous disease with diverse clinical outcomes and responses to treatment. In the past two to three decades, a ma
针对新疆干旱区城市防护林面积广阔、气候干燥缺水,工作人员测量数据任务量大,难以做到数据采集及时、准确,林业管理部门监管难度大等特点,将GSM无线通信技术及嵌入式技术结
Primary pure squamous cell carcinomas(SCC)of the duodenum are very uncommon.To the best of our knowledge,only a few cases of SCC of the duodenum exist in the re
Objective Gemcitabine, the only approved drug for the treatment of pancreatic cancer, is not very effective. Novel and effective cancer chemopreventive agents a
Oncology and Translational Medicine is an international professional academic periodical.The Journal is designed to report progress in research and the latest f
The treatment of stage Ⅲ non-small cell lung cancer(NSCLC) consisting of the heterogeneous stage subsets remains a challenge. Overall, it has been gradually re
Objective This study aimed to evaluate serum and nipple discharge levels of carcinoembryonic antigen(CEA)and cancer antigen153(CA153)and tissue cyclooxygenase-2
Objective Triple negative breast cancer (TNBC) contains a high proportion of breast cancer stem cells (BCSCs) and exhibits resistance to chemotherapy treatments